Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allocetra-OTS in severe and critical COVID-19
NCT04590053Phase 2Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Oct 2020
- Primary completion
- Feb 2021
- Countries
- 1
01
Overview
A Phase 2 trial of Allocetra in coronavirus disease 2019 (COVID-19), sponsored by Hadassah Medical Organization. Status: unknown.
02
Drugs
Allocetra
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04590053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04590053.